Antares Pharmaceuticals: Projecting Very Strong Growth in Xyosted Sales for 2020, 2021 and 2022 (ATRS, Buy, $3.89)
Key Points In my sales and earnings model for 2020, I will be using a working estimate of $53.6 million for sales of Xyosted in 2020. My working estimate is lower than two alternative scenarios laid out in this report. In Scenario 1, I arrive at a sales estimate of $70.3 million for 2020 and […]
